LINK Potential IH&S, High Confluence, $26 Target 1, $32 Target 2
🎯 TL;DR Potential IH&S + W3 Target: $26; W3 Target 2: $32; High Confluence
📈 With the recent dip to $15.3,
LINKUSDT might be forming an Inverted Head & Shoulders (IH&S) pattern with a $26 target.
The 50VWMA is acting as support in this area, and TD Sequential printed a Perfect Buy Setup (red M9) yesterday, offering additional confluence.
This retracement is also 61.8% of the previous leg up, setting a potential Wave 3 Target 1 also at $26, and a potential Wave 3 Target 2 at $32.
✅ Confirmation would be a daily close above the neckline at $19.3.
For a safer entry, wait for a daily close above $20, which is a previous resistance, a High Volume Node (HVN) and a key psychological level.
Keep an eye on $22.9 as it previously triggered a rejection.
❌ Invalidation would be a daily close below $15.3, and it would likely lead back to trading in a rectangle between $12.8 and $19.2.
If you have any questions about the TA, feel free to ask. I am always more than happy to share and discuss charts.
Not Financial Advice
📈 With the recent dip to $15.3,
LINKUSDT might be forming an Inverted Head & Shoulders (IH&S) pattern with a $26 target.The 50VWMA is acting as support in this area, and TD Sequential printed a Perfect Buy Setup (red M9) yesterday, offering additional confluence.
This retracement is also 61.8% of the previous leg up, setting a potential Wave 3 Target 1 also at $26, and a potential Wave 3 Target 2 at $32.
✅ Confirmation would be a daily close above the neckline at $19.3.
For a safer entry, wait for a daily close above $20, which is a previous resistance, a High Volume Node (HVN) and a key psychological level.
Keep an eye on $22.9 as it previously triggered a rejection.
❌ Invalidation would be a daily close below $15.3, and it would likely lead back to trading in a rectangle between $12.8 and $19.2.
If you have any questions about the TA, feel free to ask. I am always more than happy to share and discuss charts.
Not Financial Advice
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.